Evidence of Fluconazole-Resistant Candida parapsilosis Genotypes Spreading across Hospitals Located in Madrid, Spain and Harboring the Y132F ERG11p Substitution.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
16 08 2022
Historique:
pubmed: 20 7 2022
medline: 19 8 2022
entrez: 19 7 2022
Statut: ppublish

Résumé

We have been monitoring the antifungal resistance in Candida parapsilosis isolates collected from inpatients at Madrid metropolitan area hospitals for the last 3 years. The study aimed to elucidate the presence of fluconazole-resistant C. parapsilosis genotypes in Madrid. From January 2019 to December 2021, a total of 354 C. parapsilosis isolates (

Identifiants

pubmed: 35852369
doi: 10.1128/aac.00710-22
pmc: PMC9380585
doi:

Substances chimiques

Antifungal Agents 0
Fluconazole 8VZV102JFY

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0071022

Références

Microb Drug Resist. 2017 Dec;23(8):966-972
pubmed: 28353392
Front Cell Infect Microbiol. 2020 May 21;10:206
pubmed: 32509592
Med Mycol. 2021 Dec 10;60(1):
pubmed: 34718724
Front Cell Infect Microbiol. 2020 May 05;10:166
pubmed: 32432048
Antimicrob Agents Chemother. 2021 Mar 18;65(4):
pubmed: 33468487
Antimicrob Agents Chemother. 2015 Feb;59(2):1030-7
pubmed: 25451046
J Med Microbiol. 2021 Mar;70(3):
pubmed: 33599604
Mycoses. 2021 Aug;64(8):823-830
pubmed: 33934400
BMC Infect Dis. 2020 Jan 17;20(1):55
pubmed: 31952505
J Fungi (Basel). 2021 Mar 30;7(4):
pubmed: 33808442
Antimicrob Agents Chemother. 2015 Oct;59(10):6581-7
pubmed: 26259795
Antimicrob Agents Chemother. 2015;59(6):3570-3
pubmed: 25779577
Antimicrob Agents Chemother. 2020 Sep 21;64(10):
pubmed: 32690638
Clin Microbiol Rev. 2019 Feb 27;32(2):
pubmed: 30814115
J Fungi (Basel). 2022 Apr 27;8(5):
pubmed: 35628707
Clin Microbiol Infect. 2022 Aug;28(8):1113-1119
pubmed: 35439634
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S79-S94
pubmed: 30895218
Clin Microbiol Infect. 2022 Jan;28(1):140.e1-140.e4
pubmed: 34619396
Mycoses. 2020 Apr;63(4):361-368
pubmed: 31954083
J Fungi (Basel). 2020 Aug 18;6(3):
pubmed: 32824785
Clin Microbiol Infect. 2012 Jul;18(7):E246-7
pubmed: 22563750
Med Mycol. 2021 Jul 6;59(7):664-671
pubmed: 33305313
Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0124921
pubmed: 34570649
Front Cell Infect Microbiol. 2020 May 25;10:232
pubmed: 32523896
J Clin Microbiol. 2016 May;54(5):1295-303
pubmed: 26935732
Antimicrob Agents Chemother. 2014;58(3):1529-37
pubmed: 24366741
J Antimicrob Chemother. 2019 May 1;74(5):1260-1268
pubmed: 30753525
Emerg Infect Dis. 2018 Sep;24(9):1768-1770
pubmed: 30124412
Antimicrob Agents Chemother. 2021 Feb 16;:
pubmed: 33593841
Mycoses. 2020 May;63(5):471-477
pubmed: 32124485

Auteurs

Judith Díaz-García (J)

Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

Ana Gómez (A)

Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

Luis Alcalá (L)

Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain.

Elena Reigadas (E)

Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain.

Carlos Sánchez-Carrillo (C)

Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain.

Ana Pérez-Ayala (A)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Elia Gómez-García de la Pedrosa (E)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

Fernando González-Romo (F)

Hospital Universitario Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos IdISSC, Madrid, Spain.

Paloma Merino-Amador (P)

Hospital Universitario Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos IdISSC, Madrid, Spain.

María Soledad Cuétara (MS)

Hospital Universitario Severo Ochoagrid.411361.0, Leganés, Spain.

Coral García-Esteban (C)

Hospital Universitario de Getafe, Getafe, Spain.

Inmaculada Quiles-Melero (I)

Hospital Universitario La Pazgrid.81821.32, Madrid, Spain.

Nelly Daniela Zurita (ND)

Hospital Universitario de La Princesa, Madrid, Spain.

María Muñoz-Algarra (M)

Hospital Universitario Puerta de Hierro, Majadahonda, Spain.

Isabel Sánchez-Romero (I)

Hospital Universitario Puerta de Hierro, Majadahonda, Spain.

María Teresa Durán-Valle (MT)

Hospital Universitario de Móstoles, Móstoles, Spain.

Aída Sánchez-García (A)

Laboratorio Central de la CAM - URSalud, Hospital Infanta Sofía, San Sebastián de los Reyes, Spain.

Eva Alcoceba (E)

Clinical Microbiology Department, Hospital Universitari Son Espases, Palma de Mallorca, Spain.

Patricia Muñoz (P)

Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain.
Medicine Department, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

Pilar Escribano (P)

Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

Jesús Guinea (J)

Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañóngrid.410526.4, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH